Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes.
In a long term study, which covered 4 sampling periods over three years, a total number of 84 samples, specifically 28 influent, effluent, from seven WWTP located in the main cities along the Ebro river Basin (North East of Spain), as well as receiving river waters, were analyzed to assess the occurrence of 73 pharmaceuticals covering several medicinal classes. Results indicated that pharmaceuticals are widespread pollutants in the aquatic environmental. Linking the calculation of removal rates with half-lives, assuming that compound degradation followed pseudo-first order kinetics, suggested that conventional wastewater treatments applied at the seven WWTP were unable to completely remove most of the pharmaceuticals under study. The evaluation of compound degradability, in terms of half-lives, is an important task to discuss integrated solutions for mitigation of pollutants entry into the water cycle. High half-lives observed for the majority of pharmaceuticals in WWTP suggest that, in order to enhance compound degradation, higher hydraulic retention times should be required. The wide spectrum of substances detected in receiving river waters indicates that WWTP outlets are major contributors of pharmaceuticals in the aquatic environment. However, municipal wastewater treatment represents an obligatory and final treatment step prior to their release into the aquatic media, since load of pharmaceuticals in outlets were considerably reduced after treatment. Finally, hazard posed by pharmaceuticals in both surface and effluent wastewaters was assessed toward different aquatic organisms, (algae, daphnids and fish). The overall relative order of susceptibility was estimated to be algae>daphnia>fish. Results indicate that no significant risks could be associated to the presence of pharmaceuticals in those matrices, indicating that reduction of compound concentration after wastewater treatment as well as dilution factor once pharmaceuticals are discharged in receiving river water efficiently mitigate possible environmental hazards.
Gros
Meritxell
M
Department of Environmental Chemistry, IDAEA-CSIC, c/Jordi Girona 18-26, 08034 Barcelona, Spain; Institut Catalàde Recerca de l'Aigua (ICRA), c/ Emili Grahit 101, 17003 Girona, Spain.
Petrović
Mira
M
Department of Environmental Chemistry, IDAEA-CSIC, c/Jordi Girona 18-26, 08034 Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Passeig Lluis Companys 23, 80010 Barcelona, Spain. Electronic address: mpeqam@cid.csic.es.
Ginebreda
Antoni
A
Department of Environmental Chemistry, IDAEA-CSIC, c/Jordi Girona 18-26, 08034 Barcelona, Spain.
Barceló
Damià
D
Department of Environmental Chemistry, IDAEA-CSIC, c/Jordi Girona 18-26, 08034 Barcelona, Spain; Institut Catalàde Recerca de l'Aigua (ICRA), c/ Emili Grahit 101, 17003 Girona, Spain.
D000818:Animals; D003621:Daphnia / Q000187:drug effects; D004784:Environmental Monitoring; D056890:Eukaryota / Q000187:drug effects; D005399:Fishes / Q000378:metabolism; D005618:Fresh Water / Q000737:chemistry*; D004364:Pharmaceutical Preparations / Q000032:analysis*; D018570:Risk Assessment; D018675:Toxicity Tests; D014865:Waste Disposal, Fluid / Q000379:methods*; D014874:Water Pollutants, Chemical / Q000032:analysis* / Q000633:toxicity
D004364:Pharmaceutical Preparations; D014874:Water Pollutants, Chemical